Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics
Public ClinicalTrials.gov record NCT00773279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-centre, Randomised, Open-label, Cross-over Study to Explore Effectiveness, Safety, and Preference of a New Disposable Pen PDS290 Versus FlexPen® in Subjects With Type 1 or Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The aim of this clinical trial is to assess and compare the effect on blood sugar control of insulin detemir and insulin aspart or insulin detemir alone administered by a insulin pen PDS290 (FlexTouch®) versus a Novo Nordisk marketed insulin pen (FlexPen®) in subjects with type 1 or type 2 diabetes mellitus. Furthermore, the subject's preference of the devices will be investigated by the use of questionnaires.
Study identification
- NCT ID
- NCT00773279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 242 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Jun 2009 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- Mar 27, 2017
2008 – 2009
United States locations
- U.S. sites
- 65
- U.S. states
- 28
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Burlingame | California | 94010 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Encino | California | 91436 | — |
| Novo Nordisk Investigational Site | Escondido | California | 92025 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Mission Viejo | California | 92691 | — |
| Novo Nordisk Investigational Site | Orange | California | 92869 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Salinas | California | 93901 | — |
| Novo Nordisk Investigational Site | Santa Monica | California | 90404 | — |
| Novo Nordisk Investigational Site | Tustin | California | 92780 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Aurora | Colorado | 80045 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80909 | — |
| Novo Nordisk Investigational Site | Golden | Colorado | 80401 | — |
| Novo Nordisk Investigational Site | Boca Raton | Florida | 33433 | — |
| Novo Nordisk Investigational Site | Hollywood | Florida | 33021 | — |
| Novo Nordisk Investigational Site | Maitland | Florida | 32751 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33143 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33156 | — |
| Novo Nordisk Investigational Site | Ocala | Florida | 34471 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Athens | Georgia | 30606 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Savannah | Georgia | 31406 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96814 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60616 | — |
| Novo Nordisk Investigational Site | Lafayette | Indiana | 47904 | — |
| Novo Nordisk Investigational Site | Wichita | Kansas | 67226 | — |
| Novo Nordisk Investigational Site | Bowling Green | Kentucky | 42101-1759 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21204 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Jefferson City | Missouri | 65109 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63141 | — |
| Novo Nordisk Investigational Site | Butte | Montana | 59701 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68114 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89030 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89101 | — |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | — |
| Novo Nordisk Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Tabor City | North Carolina | 28463 | — |
| Novo Nordisk Investigational Site | Fargo | North Dakota | 58104 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45439 | — |
| Novo Nordisk Investigational Site | Gallipolis | Ohio | 45631-1560 | — |
| Novo Nordisk Investigational Site | Kettering | Ohio | 45429 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Medford | Oregon | 97504-8491 | — |
| Novo Nordisk Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Novo Nordisk Investigational Site | Carlisle | Pennsylvania | 17015 | — |
| Novo Nordisk Investigational Site | Little River | South Carolina | 29566 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Arlington | Texas | 76014 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Hurst | Texas | 76054 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84403 | — |
| Novo Nordisk Investigational Site | Virginia Beach | Virginia | 23462 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00773279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00773279 live on ClinicalTrials.gov.